112 related articles for article (PubMed ID: 2686319)
21. [Description of a case of dystonia musculorum deformans treated with L-dopa].
Balottin U; Lanzi G; Zambrino CA
Riv Neurobiol; 1981; 27(34):584-90. PubMed ID: 7052665
[No Abstract] [Full Text] [Related]
22. [Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
Kamenetskiĭ VK
Klin Med (Mosk); 1984 Apr; 62(4):112-6. PubMed ID: 6737958
[No Abstract] [Full Text] [Related]
23. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
24. The nurse's role in clinical trials.
Amyot D; Gray P; Demong C; Wilson W; Murphy D; Watson J; Duff J
Can Nurse; 1996 Nov; 92(10):30-2. PubMed ID: 9095759
[TBL] [Abstract][Full Text] [Related]
25. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
Mundinger F; Milios E
Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
[No Abstract] [Full Text] [Related]
26. [Treatment of the hyperkinetic form of cerebral palsy in children].
Mel'nichuk PV; Sosnovskaia LS; Khaĭlova IM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(10):1463-7. PubMed ID: 1210919
[No Abstract] [Full Text] [Related]
27. Atypical presentations of dopa-responsive dystonia.
Bandmann O; Marsden CD; Wood NW
Adv Neurol; 1998; 78():283-90. PubMed ID: 9750924
[No Abstract] [Full Text] [Related]
28. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
Warnes DM; Tomas FM; Ballard FJ
Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
[TBL] [Abstract][Full Text] [Related]
29. [Functional state of non-specific brain systems in dystonia musculorum deformans].
Veĭn AM; Golubev VL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):509-14. PubMed ID: 207060
[TBL] [Abstract][Full Text] [Related]
30. Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Mortimer D; Gelfius CD; Potts MA
PM R; 2013 Dec; 5(12):1077-80. PubMed ID: 24332231
[TBL] [Abstract][Full Text] [Related]
31. The use of dimethothiazine in the treatment of childhood cerebral palsy.
Griffiths MI; Bowie EM
Dev Med Child Neurol; 1973 Feb; 15(1):25-32. PubMed ID: 4580875
[No Abstract] [Full Text] [Related]
32. A new syndrome of axial muscle rigidity associated with etretinate therapy.
Albin RL; Silverman AK; Ellis CN; Voorhees JJ; Albers JW
Mov Disord; 1988; 3(1):70-6. PubMed ID: 3173366
[TBL] [Abstract][Full Text] [Related]
33. Dystonic movement disorders and their treatment--report of three cases.
Kaneko Y; Kumashiro H; Yashima Y; Kowada M
Fukushima J Med Sci; 1978; 25(3-4):109-20. PubMed ID: 756385
[No Abstract] [Full Text] [Related]
34. Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia.
de Yebenes JG; Moskowitz C; Fahn S; Saint-Hilaire MH
Adv Neurol; 1988; 50():101-11. PubMed ID: 3400489
[No Abstract] [Full Text] [Related]
35. Dystonia--L-dopa responsive or juvenile parkinsonism?
Rondot P; Ziegler M
J Neural Transm Suppl; 1983; 19():273-81. PubMed ID: 6583312
[TBL] [Abstract][Full Text] [Related]
36. [Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
Brin IL; Drozdov AZ; Kovaleva IA; Filatova TS; Kogan BM
Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):7-12. PubMed ID: 7975996
[TBL] [Abstract][Full Text] [Related]
37. [Dopa-responsive dystonia].
Kaakkola S; Iivanainen M
Duodecim; 1994; 110(13):1271-4. PubMed ID: 7497939
[No Abstract] [Full Text] [Related]
38. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
39. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
Olanow CW; Alberts MJ
Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
[No Abstract] [Full Text] [Related]
40. Dopa-responsive dystonia presenting as delayed and awkward gait.
Cheyette BN; Cheyette SN; Cusmano-Ozog K; Enns GM
Pediatr Neurol; 2008 Apr; 38(4):273-5. PubMed ID: 18358407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
